Researcher
Herlinde Dumez
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Publications
1 - 10 of 64
- Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral Center.(2024)
Authors: Dirk De Ridder, Anne-Sophie Van Rompuy, Herlinde Dumez, Gert De Meerleer, Karolien Goffin, Hendrik Van Poppel, Steven Joniau, Maarten Albersen
Pages: 57 - 65 - Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients(2023)
Authors: Alexander Giesen, Loic Baekelandt, Herlinde Dumez, Wouter Everaerts, Frank Claessens, Steven Joniau
- Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses(2022)
Authors: Herlinde Dumez
Pages: E783 - E795 - First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours(2022)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 135 - 145 - Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study(2022)
Authors: Annouschka Laenen, Marcella Baldewijns, Herlinde Dumez, Paul Clement, Hans Wildiers, Patrick Schöffski, Eduard Roussel, Lisa Kinget, Maarten Albersen, Benoit Beuselinck
Pages: 22 - 29 - Retrospective Analysis of the Clinical Presentation, Treatment and Outcome of Angiosarcoma in a Sarcoma Referral Center(2021)
Authors: Patrick Schöffski, Hans Wildiers, Herlinde Dumez, Daphne Hompes, Raf Sciot, Annouschka Laenen, Jerry Lee
Pages: 322 - 331 - Management of Synovial Sarcoma in a Tertiary Referral Center: A Retrospective Analysis of 134 Patients(2021)
Authors: Lore De Cock, Annouschka Laenen, Herlinde Dumez, Hazem Wafa, Daphne Hompes, Dirk Van Raemdonck, Paul De Leyn, Raf Sciot, Esther Hauben, Maria Debiec-Rychter, et al.
Pages: 232 - 240 - Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".(2021)
Authors: Patrick Schöffski, Daphne Hompes, Veerle Boecxstaens, Paul De Leyn, Willy Coosemans, Dirk Van Raemdonck, Esther Hauben, Raf Sciot, Paul Clement, Oliver Bechter, et al.
Pages: 4653987 - TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity(2021)
Authors: Herlinde Dumez
Pages: S630 - S631 - Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma(2020)
Authors: Herlinde Dumez
Pages: 202 - 211